CTSO
Price
$0.86
Change
+$0.05 (+6.17%)
Updated
Dec 18 closing price
77 days until earnings call
NEO
Price
$16.49
Change
-$1.06 (-6.04%)
Updated
Dec 18 closing price
68 days until earnings call
Ad is loading...

CTSO vs NEO

Header iconCTSO vs NEO Comparison
Open Charts CTSO vs NEOBanner chart's image
Cytosorbents
Price$0.86
Change+$0.05 (+6.17%)
Volume$110.96K
CapitalizationN/A
NeoGenomics
Price$16.49
Change-$1.06 (-6.04%)
Volume$744.2K
CapitalizationN/A
CTSO vs NEO Comparison Chart
Loading...
CTSO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTSO vs. NEO commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTSO is a StrongBuy and NEO is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (CTSO: $0.86 vs. NEO: $16.49)
Brand notoriety: CTSO and NEO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CTSO: 81% vs. NEO: 109%
Market capitalization -- CTSO: $49.22M vs. NEO: $2.01B
CTSO [@Medical Specialties] is valued at $49.22M. NEO’s [@Medical Specialties] market capitalization is $2.01B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTSO’s FA Score shows that 0 FA rating(s) are green whileNEO’s FA Score has 0 green FA rating(s).

  • CTSO’s FA Score: 0 green, 5 red.
  • NEO’s FA Score: 0 green, 5 red.
According to our system of comparison, CTSO is a better buy in the long-term than NEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTSO’s TA Score shows that 4 TA indicator(s) are bullish while NEO’s TA Score has 5 bullish TA indicator(s).

  • CTSO’s TA Score: 4 bullish, 5 bearish.
  • NEO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, NEO is a better buy in the short-term than CTSO.

Price Growth

CTSO (@Medical Specialties) experienced а -2.58% price change this week, while NEO (@Medical Specialties) price change was -9.25% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.50%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +1.07%.

Reported Earning Dates

CTSO is expected to report earnings on Mar 06, 2025.

NEO is expected to report earnings on Feb 25, 2025.

Industries' Descriptions

@Medical Specialties (-4.50% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEO($2.01B) has a higher market cap than CTSO($49.2M). NEO YTD gains are higher at: 1.916 vs. CTSO (-22.703). NEO has higher annual earnings (EBITDA): -17.61M vs. CTSO (-29.18M). NEO has more cash in the bank: 415M vs. CTSO (14.1M). CTSO has less debt than NEO: CTSO (18.3M) vs NEO (612M). NEO has higher revenues than CTSO: NEO (592M) vs CTSO (31.1M).
CTSONEOCTSO / NEO
Capitalization49.2M2.01B2%
EBITDA-29.18M-17.61M166%
Gain YTD-22.7031.916-1,185%
P/E RatioN/A49.50-
Revenue31.1M592M5%
Total Cash14.1M415M3%
Total Debt18.3M612M3%
FUNDAMENTALS RATINGS
CTSO vs NEO: Fundamental Ratings
CTSO
NEO
OUTLOOK RATING
1..100
7377
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9893
PRICE GROWTH RATING
1..100
6542
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CTSO's Valuation (43) in the Medical Specialties industry is in the same range as NEO (71) in the Medical Or Nursing Services industry. This means that CTSO’s stock grew similarly to NEO’s over the last 12 months.

CTSO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that CTSO’s stock grew similarly to NEO’s over the last 12 months.

NEO's SMR Rating (93) in the Medical Or Nursing Services industry is in the same range as CTSO (98) in the Medical Specialties industry. This means that NEO’s stock grew similarly to CTSO’s over the last 12 months.

NEO's Price Growth Rating (42) in the Medical Or Nursing Services industry is in the same range as CTSO (65) in the Medical Specialties industry. This means that NEO’s stock grew similarly to CTSO’s over the last 12 months.

NEO's P/E Growth Rating (100) in the Medical Or Nursing Services industry is in the same range as CTSO (100) in the Medical Specialties industry. This means that NEO’s stock grew similarly to CTSO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CTSONEO
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 10 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 1 day ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Ad is loading...
CTSO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL248.05-5.43
-2.14%
Apple
SPY586.28-18.01
-2.98%
SPDR® S&P 500® ETF Trust
BTC.X100041.540000-6099.062500
-5.75%
Bitcoin cryptocurrency
TSLA440.13-39.73
-8.28%
Tesla
GME28.55-2.71
-8.67%
GameStop Corp

CTSO and

Correlation & Price change

A.I.dvisor tells us that CTSO and CNMD have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTSO and CNMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTSO
1D Price
Change %
CTSO100%
+5.91%
CNMD - CTSO
24%
Poorly correlated
-2.68%
RVTY - CTSO
23%
Poorly correlated
-4.89%
BJDX - CTSO
22%
Poorly correlated
-4.79%
NEO - CTSO
22%
Poorly correlated
-6.04%
RGEN - CTSO
21%
Poorly correlated
-6.83%
More

NEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with FLGT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then FLGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
-6.04%
FLGT - NEO
49%
Loosely correlated
-3.60%
VCYT - NEO
43%
Loosely correlated
-6.42%
BLFS - NEO
41%
Loosely correlated
-7.03%
CRL - NEO
41%
Loosely correlated
-3.26%
AORT - NEO
40%
Loosely correlated
-3.84%
More